Episode Details

New research reveals GLP-1 drugs like semaglutide may slash asthma attacks by nearly 40%—offering surprising respiratory benefits beyond weight loss and diabetes management. The findings, based on tens of thousands of patient records, show the strongest effects in those with severe asthma, likely due to anti-inflammatory properties. But experts caution: this isn’t a reason to prescribe these drugs for breathing issues alone. More trials are needed, and current asthma/COPD treatments shouldn’t be changed yet. Still, it’s a compelling hint that metabolic and respiratory health are deeply connected—and worth watching closely.

Listen in comfort:
Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/1c3fcb1e6e50a7df